Persistent delusional disorders

F5_DELUSIO

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — F22 Hospital discharge: ICD-9 — 2971 Hospital discharge: ICD-8 — 297 Cause of death: ICD-10 — F22 Cause of death: ICD-9 — 2971 Cause of death: ICD-8 — 297 2 out of 7 registries used, show all original rules.	3075
4. Check minimum number of events None	3075
5. Include endpoints None	3075
6. Filter based on genotype QC (FinnGen only)	3075

Control definitions (FinnGen only)

Control exclude: F5_SCHIZO

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: F20-F29
Name in latin: Perturbationes delusionales persistentes

NAME	F5_DELUSIO
CONTROL_EXCLUDE	F5_SCHIZO
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	F22
HD_ICD_9	2971
HD_ICD_8	297
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	F22
COD_ICD_9	2971
COD_ICD_8	297
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Persistent delusional disorders based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	38824	23201	15266
Only index persons	30346	18429	11917
Unadjusted period prevalence (%)
Whole population	0.57	0.66	0.43
Only index persons	0.59	0.68	0.45
Median age at first event (years)
Whole population	57.29	63.88	47.22
Only index persons	54.89	61.61	44.51

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3075	1691	1384
Unadjusted period prevalence (%)	0.59	0.58	0.61
Median age at first event (years)	47.62	51.67	42.67

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2851: Matched controls
28508

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

N05AH03

ATC

olanzapine; systemic

79.8

323.0

1381

331

F29

ICD-10 Finland

Unspecified nonorganic psychosis

1806.7

323.0

1109

N04AA02

ATC

biperiden; systemic

99.5

323.0

438

N05AH02

ATC

clozapine; systemic

1347.2

323.0

454

N05AA02

ATC

levomepromazine; systemic

23.9

323.0

583

303

F20.9

ICD-10 Finland

Schizophrenia, unspecified

6100.7

323.0

515

N05AF03

ATC

chlorprothixene; systemic

40.3

323.0

462

136

N05AB03

ATC

perphenazine; systemic, rectal

92.2

323.0

1011

169

N05AX12

ATC

aripiprazole; systemic

63.4

323.0

797

173

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

+∞

323.0

662

N05AH04

ATC

quetiapine; oral

13.0

323.0

1512

2276

F22.9

ICD-10 Finland

Persistent delusional disorder, unspecified

2767.0

323.0

605

N05AX08

ATC

risperidone; systemic

56.8

323.0

1706

729

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

184.7

323.0

2061

396

2971A

ICD-9 Finland

Paranoid states, Paranoia

+∞

323.0

324

F22.0

ICD-10 Finland

Delusional disorder

10584.5

323.0

2160

P72

ICPC

Schizophrenia

394.2

323.0

459

F20.09

ICD-10 Finland

Paranoid schizophrenia UNS

+∞

305.8

288

188

Kela drug reimbursment

Psychosis requiring demanding treatment

810.6

301.8

292

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

2719.5

272.1

259

P29

ICPC

Psychological sympt/compl other

12.3

270.9

519

506

N05AA01

ATC

chlorpromazine; systemic, rectal

145.9

262.8

277

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

+∞

261.5

247

N05BA04

ATC

oxazepam; oral

4.3

252.7

1233

4256

P99

ICPC

Psychological disorders other

24.5

247.4

358

166

N05AC02

ATC

thioridazine; oral

40.2

240.9

306

N05AD01

ATC

haloperidol; systemic

19.0

239.8

378

227

N05BA06

ATC

lorazepam; systemic, sublingual

11.3

239.0

476

495

N03AG01

ATC

valproic acid; systemic, rectal

9.6

234.2

512

633

N05AF05

ATC

zuclopenthixol; systemic

258.2

233.9

237

F20.04

ICD-10 Finland

Paranoid schizophrenia with partial recurrence

+∞

233.6

221

N05CD07

ATC

temazepam; oral

5.5

229.0

781

1819

F23.3

ICD-10 Finland

Other acute predominantly delusional psychotic disorders

2123.6

217.4

208

N06AB04

ATC

citalopram; systemic

4.1

216.6

1066

3592

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

22.9

212.8

314

153

F20.0

ICD-10 Finland

Paranoid schizophrenia

+∞

207.9

197

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

23.6

194.5

284

133

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

24.6

189.5

273

122

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

6.5

189.5

546

1008

N05BA01

ATC

diazepam; systemic, rectal

4.7

188.5

743

1976

2989X

ICD-9 Finland

Other nonorganic psychoses, Unspecified psychosis

+∞

186.5

177

F22.8

ICD-10 Finland

Other persistent delusional disorders

+∞

186.5

177

IGY02

NOMESCO Finland

Psychiatric monitoring contact

23.1

183.1

269

128

F32.9

ICD-10 Finland

Depressive episode, unspecified

4.8

176.5

671

1705

P98

ICPC

Psychosis NOS/other

212.0

174.2

179

T36

ICD-10 Finland

Poisoning by systemic antibiotics

10.0

169.1

357

403

N06AB06

ATC

sertraline; oral

4.9

162.1

599

1464

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

20.1

160.7

247

134

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

22.5

152.2

225

108

N05AN01

ATC

lithium; oral

17.7

147.5

237

145

N05AX13

ATC

paliperidone; systemic

745.1

145.3

142

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

10.5

140.8

287

300

F21

ICD-10 Finland

Schizotypal disorder

+∞

136.5

130

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

6.0

133.8

399

749

SPAT1240

SPAT

Therapeutic discussion

4.5

128.5

515

1340

F25.00

ICD-10 Finland

Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms

+∞

128.1

122

F20

ICD-10 Finland

Schizophrenia

+∞

122.8

117

F25.10

ICD-10 Finland

Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms

+∞

121.7

116

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

22.8

117.2

172

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

4.9

116.3

422

985

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

19.7

115.5

178

N05CF01

ATC

zopiclone; oral

2.6

115.5

1198

6199

F20.02

ICD-10 Finland

Paranoid schizophrenia stable periodically

+∞

115.4

110

29700

ICD-8 Finland

Paranoid states, Paranoia

+∞

114.3

109

IGY99

NOMESCO Finland

Other psychiatric treatment contact

18.1

111.4

177

104

F25.20

ICD-10 Finland

Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms

1109.9

110.2

107

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

47.2

106.9

131

F20.39

ICD-10 Finland

Undifferentiated schizophrenia UNS

+∞

106.9

102

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

14.0

105.8

186

141

N06AX11

ATC

mirtazapine; oral

2.5

105.8

1147

6000

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

25.7

105.4

149

IER04

NOMESCO Finland

Rehabilitative psychiatric group intervention, functional

66.4

104.6

121

F20.01

ICD-10 Finland

Paranoid schizophrenia periodically with gradual deterioration

+∞

103.8

F99

ICD-10 Finland

Mental disorder, not otherwise specified

12.8

102.7

188

156

F23.99

ICD-10 Finland

Acute and transient psychosis, unspecified UNS

+∞

102.7

N05AE04

ATC

ziprasidone; systemic

90.5

101.8

113

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

4.9

98.9

348

779

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

29.6

97.9

133

F20.08

ICD-10 Finland

Paranoid schizophrenia other definite

+∞

95.3

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

9.8

95.0

199

216

SPAT1254

SPAT

Administration of medicine

3.1

94.7

598

2220

N06AB03

ATC

fluoxetine; oral

3.4

94.4

535

1836

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

7.2

92.9

237

354

F60.9

ICD-10 Finland

Personality disorder, unspecified

18.3

92.0

145

N07BB01

ATC

disulfiram; oral

6.1

91.3

263

464

N05AL01

ATC

sulpiride; systemic

15.3

91.1

154

106

SPAT1234

SPAT

Support of social functional capacity

5.4

90.2

290

585

IGV01

NOMESCO Finland

Psychiatric network contact

57.9

89.8

106

F22

ICD-10 Finland

Persistent delusional disorders

895.6

89.2

F20.5

ICD-10 Finland

Residual schizophrenia

884.9

88.2

N06AX16

ATC

venlafaxine; oral

3.1

88.0

557

2060

N03AX09

ATC

lamotrigine; oral

5.8

87.6

263

488

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

9.4

86.5

186

211

SPAT1222

SPAT

Counselling/guidance promoting independent living

3.0

84.3

585

2293

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

23.3

83.4

121

F10.20

ICD-10 Finland

Alcohol dependence currently independent

10.3

82.4

168

173

R44.3

ICD-10 Finland

Hallucinations, unspecified

57.7

80.5

F61.0

ICD-10 Finland

Mixed personality disorders

11.9

80.1

151

133

SPAT1307

SPAT

Psychosocial counselling and guidance

5.2

79.6

264

549

F23.90

ICD-10 Finland

Acute and transient psychosis, unspecified without acute stress factor

+∞

79.5

A06AD11

ATC

lactulose; oral

2.9

79.1

557

2196

P01

ICPC

Feeling anxious/nervous/tense

3.7

77.2

376

1132

F20.3

ICD-10 Finland

Undifferentiated schizophrenia

747.3

74.6

N05BE01

ATC

buspirone; oral

7.4

74.4

185

265

IFA99

NOMESCO Finland

Other psychiatric pharmacotherapy service

51.0

73.9

N05AF01

ATC

flupentixol; systemic

11.5

73.7

141

128

EBA00

NOMESCO Finland

Extraction of tooth

2.2

73.3

1005

5638

F20.34

ICD-10 Finland

Undifferentiated schizophrenia with partial recurrence

+∞

73.2

F25.21

ICD-10 Finland

Schizoaffective syndrome, mixed type with prolonged schizophrenic than bipolar symptoms

+∞

73.2

N03AE01

ATC

clonazepam; systemic

4.3

73.1

291

730

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

3.7

73.0

346

1016

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

12.7

73.0

133

109

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

9.8

72.4

151

162

N05AE03

ATC

sertindole; oral

705.1

70.4

N06AX03

ATC

mianserin; oral

4.8

70.1

248

552

F28

ICD-10 Finland

Other nonorganic psychotic disorders

+∞

69.0

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

3.6

68.3

337

1020

P28

ICPC

Limited function/disability (P)

22.5

68.3

100

IER02

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, group

36.3

68.3

F20.10

ICD-10 Finland

Raise schizophrenia continuously

+∞

66.9

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

3.6

66.3

331

1011

IEV99

NOMESCO Finland

Other psychiatric network intervention

105.5

66.1

F20.8

ICD-10 Finland

Other schizophrenia

+∞

65.9

2953E

ICD-9 Finland

Schizophrenic psychoses, Paranoid type[PARANOIDISTYYPPINEN SKITSOFRENIA,KROONINEN AKUUTTI]

+∞

65.9

A28

ICPC

Limited function/disability NOS

2.7

65.3

527

2235

F25.01

ICD-10 Finland

Schizoaffective syndrome, manic type with prolonged schizophrenic than bipolar symptoms

+∞

63.8

F60.0

ICD-10 Finland

Paranoid personality disorder

49.4

63.6

F25.11

ICD-10 Finland

Schizoaffective syndrome, depressive type with prolonged schizophrenic than bipolar symptoms

+∞

62.7

2988A

ICD-9 Finland

Other nonorganic psychoses, Other and unspecified reactive psychosis

+∞

62.7

P50

ICPC

Psychological, Medication/prescr/renewal

43.9

62.3

SPAT1243

SPAT

Psychiatric/psychological examination

7.4

61.8

152

214

F23.8

ICD-10 Finland

Other acute and transient psychotic disorders

+∞

61.7

29830

ICD-8 Finland

Other psychoses, Acute paranoid reaction

+∞

61.7

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

10.0

60.9

125

130

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

3.4

59.9

311

977

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

5.1

59.6

198

410

29999

ICD-8 Finland

Unspecified psychosis

+∞

59.6

3018X

ICD-9 Finland

Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]

21.6

59.4

F20.03

ICD-10 Finland

Paranoid schizophrenia periodically with gradual improvement

+∞

58.5

R44.0

ICD-10 Finland

Auditory hallucinations

30.4

57.4

F31.20

ICD-10 Finland

Bipolar disorder, manic episode with mood-congruent psychotic symptoms

21.3

57.2

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

13.8

57.1

100

N05BA12

ATC

alprazolam; oral

2.8

56.1

399

1555

N06AB05

ATC

paroxetine; oral

3.6

55.8

273

816

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.8

55.8

397

1546

IEY01

NOMESCO Finland

Psychoeducation, individual

27.8

55.4

29530

ICD-8 Finland

Schizophrenia, Paranoid type

+∞

55.4

IEY02

NOMESCO Finland

Intensified psychiatric outpatient care, Assertive Community Treatment (ACT)

120.4

55.0

T90

ICPC

Diabetes non-insulin dependent

2.2

54.6

694

3671

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

35.8

54.3

OAB43

SPAT

0.2

54.2

2697

3018D

ICD-9 Finland

Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]

30.7

53.9

N06AB10

ATC

escitalopram; oral

2.2

53.6

643

3306

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

4.4

53.4

205

493

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

9.6

53.0

111

120

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

11.3

52.8

101

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

12.0

52.7

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

9.6

52.0

109

118

A10BA02

ATC

metformin; oral

2.0

51.6

820

4745

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

2.0

50.6

817

4751

P27

ICPC

Fear of mental disorder

14.8

50.2

N05AD03

ATC

melperone; systemic

9.7

50.0

104

111

C07AA05

ATC

propranolol; systemic

2.2

49.7

600

3082

F23.91

ICD-10 Finland

Acute and transient psychosis, unspecified without acute stress factor

496.2

49.5

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

2.1

49.0

697

3842

IEY08

NOMESCO Finland

Psychiatric coaching, domestic and community skills

91.7

49.0

IGY02

SPAT

30.2

48.5

P73

ICPC

Affective psychosis

36.6

47.7

R53

ICD-10 Finland

Malaise and fatigue

2.1

47.4

637

3422

2954A

ICD-9 Finland

Schizophrenic psychoses, Acute schizophrenic episode

166.1

47.0

F60.2

ICD-10 Finland

Dissocial personality disorder

44.7

46.4

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

2.4

46.2

443

2029

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.8

45.2

309

1167

M03BX02

ATC

tizanidine; oral

0.6

45.1

971

13638

AA1AD

NOMESCO Finland

CT of head and brain

2.0

44.9

701

3990

F25.2

ICD-10 Finland

Schizoaffective disorder, mixed type

+∞

44.9

N05BA02

ATC

chlordiazepoxide; systemic

6.1

44.4

125

212

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.0

43.9

708

4077

SPAT1301

SPAT

No procedures

1.9

43.6

905

5708

N06AA12

ATC

doxepin; systemic

3.5

43.5

220

672

F19.21

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances currently independent but staying in a controlling environment

57.6

43.5

F05.9

ICD-10 Finland

Delirium, unspecified

7.0

43.2

110

163

R1210

NOMESCO Finland

Medical assessment of need and possibilities to rehabilitation

10.8

43.0

IGP01

NOMESCO Finland

Psychiatric family contact

39.3

42.9

29798

ICD-8 Finland

Paranoid states, Other

+∞

42.8

M01AH05

ATC

etoricoxib; oral

0.6

42.6

911

12894

K02.1

ICD-10 Finland

Caries of dentine

1.7

41.9

1537

11558

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

21.1

41.8

2953C

ICD-9 Finland

Schizophrenic psychoses, Paranoid type[PARANOIDISTYYPPINEN SKITSOFRENIA,KROONINEN]

+∞

41.8

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

11.4

41.2

P74

ICPC

Anxiety disorder/anxiety state

4.6

41.0

149

339

P15

ICPC

Chronic alcohol abuse

4.9

40.9

139

295

P76

ICPC

Depressive disorder

3.3

40.5

216

687

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

12.9

40.3

IER01

NOMESCO Finland

Psychoeducation, group

22.7

40.1

N05AE05

ATC

lurasidone; oral

45.2

40.1

F23.00

ICD-10 Finland

Acute polymorphic psychosis without actual schizophrenic disease picture without acute stress factor

+∞

39.7

2959A

ICD-9 Finland

Schizophrenic psychoses, Unspecified schizophrenia[ERILAISTUMATON SKITSOFRENIA,TARKEMMIN MÄÄRITTELEMÄT]

+∞

39.7

29599

ICD-8 Finland

Schizophrenia, Unspecified type

+∞

39.7

F41.1

ICD-10 Finland

Generalized anxiety disorder

3.9

39.4

169

450

9691A

ICD-9 Finland

Poisoning by psychotropic agents, Phenothiazine-based tranquillisers

51.9

38.6

SAA01

NOMESCO Finland

Simple examination of mouth

1.7

38.3

1875

15136

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

3.4

38.1

194

595

N06AB08

ATC

fluvoxamine; oral

4.9

38.1

130

277

IEY19

NOMESCO Finland

Psychiatric health counselling and guidance

85.3

37.9

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

8.7

37.8

F20.4

ICD-10 Finland

Post-schizophrenic depression

+∞

37.6

F25.0

ICD-10 Finland

Schizoaffective disorder, manic type

+∞

37.6

F25.1

ICD-10 Finland

Schizoaffective disorder, depressive type

+∞

37.6

29580

ICD-8 Finland

Schizophrenia, Other

+∞

37.6

2968A

ICD-9 Finland

Affective psychoses, Manic-depressive psychosis, other and unspecified

9.9

37.2

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

8.0

37.1

111

IBA02

NOMESCO Finland

Evaluation of need for psychiatric rehabilitation

23.4

37.1

F06.2

ICD-10 Finland

Organic delusional [schizophrenia-like] disorder

70.9

37.0

N06AA09

ATC

amitriptyline; systemic

2.4

36.8

336

1490

IBZ02

NOMESCO Finland

Somatic assessment of psychiatric patient

32.5

36.7

AA400

NOMESCO Finland

Electroconvulsive therapy

14.4

36.4

N05AB01

ATC

dixyrazine; systemic

8.6

36.3

103

Kela drug reimbursment

Diabetes, insulin-treated

1.8

36.2

754

4703

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

23.6

35.8

2957A

ICD-9 Finland

Schizophrenic psychoses, Schizo-affective type

+∞

35.5

F20.05

ICD-10 Finland

Paranoid schizophrenia with complete recurrence

+∞

35.5

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.1

35.4

447

2307

RS220

NOMESCO Finland

7.6

35.3

113

F10.24

ICD-10 Finland

Alcohol depence active use

7.7

35.0

111

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

9.7

35.0

F23.9

ICD-10 Finland

Acute and transient psychotic disorder, unspecified

351.4

35.0

R56.8

ICD-10 Finland

Other and unspecified convulsions

3.4

34.9

177

541

F61

ICD-10 Finland

Mixed and other personality disorders

20.3

34.8

Z03

ICPC

Housing/neighbourhood problem

13.9

34.8

IAB12

NOMESCO Finland

Psychiatric psychosis consultation

+∞

34.4

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.8

33.7

672

4116

N06AG02

ATC

moclobemide; oral

3.3

33.7

176

551

F39

ICD-10 Finland

Unspecified mood [affective] disorder

6.7

33.5

133

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.7

33.4

831

5458

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

3.5

33.4

164

489

F25

ICD-10 Finland

Schizoaffective disorders

+∞

33.4

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.7

32.9

234

902

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

10.5

32.6

B18.2

ICD-10 Finland

Chronic viral hepatitis C

7.4

32.5

110

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

7.5

32.4

107

RT250

NOMESCO Finland

32.8

32.2

G21.1

ICD-10 Finland

Other drug-induced secondary parkinsonism

32.8

32.2

2959C

ICD-9 Finland

Schizophrenic psychoses, Unspecified schizophrenia[ERILAISTUMATON SKITSOFRENIA,KROONINEN]

+∞

31.3

F20.20

ICD-10 Finland

Catatonic schizophrenia continuously

+∞

31.3

F23.20

ICD-10 Finland

Acute schizophrenia-like psychosis without acute stress factor

+∞

31.3

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

4.9

31.2

104

217

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

14.7

31.0

IAB14

NOMESCO Finland

Geriatric psychiatry consultation

42.7

30.9

N05AC01

ATC

periciazine; systemic

16.6

30.6

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.6

30.6

1384

10628

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.8

30.6

665

4168

WX290

NOMESCO Finland

Other blockade of nerve

1.6

30.4

1143

8369

N03AF01

ATC

carbamazepine; oral, rectal

3.0

30.3

181

623

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

5.7

30.2

157

F51.0

ICD-10 Finland

Nonorganic insomnia

2.1

30.2

371

1884

SPAT1252

SPAT

Overall medication plan or its review

2.6

30.2

232

935

KMAK

NOMESCO Finland

1.6

30.1

1393

10741

D12

ICPC

Constipation

4.1

30.1

120

300

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

5.8

29.9

155

SPAT1260

SPAT

Consultation of another employee

1.9

29.8

498

2850

2961E

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,VAIKEA-ASTEINEN+PSYKOOT PIIRTEI]

28.9

29.8

ICZ04

NOMESCO Finland

Preparation of psychiatric treatment plan

83.5

29.8

IFA99

SPAT

156.6

29.7

ICB03

SPAT

156.6

29.7

F10.25

ICD-10 Finland

Alcohol dependence continuous use

5.5

29.6

169

K08.3

ICD-10 Finland

Retained dental root

2.6

29.5

227

913

F10.09

ICD-10 Finland

Alcohol intoxication UNS

5.1

29.5

191

F40.9

ICD-10 Finland

Phobic anxiety disorder, unspecified

17.3

29.2

F20.32

ICD-10 Finland

Undifferentiated schizophrenia stable periodically

+∞

29.2

2959E

ICD-9 Finland

Schizophrenic psychoses, Unspecified schizophrenia[ERILAISTUMATON SKITSOFRENIA,KROONINEN AKUUTTI VAIHE]

+∞

29.2

F34.1

ICD-10 Finland

Dysthymia

3.6

29.1

137

395

IEZ99

NOMESCO Finland

Other psychiatric rehabilitation intervention

57.3

29.1

N06AA04

ATC

clomipramine; systemic

5.5

29.0

161

P20

ICPC

Memory disturbance

2.1

28.9

343

1712

P06

ICPC

Sleep disturbance

2.3

28.8

292

1359

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.6

28.7

1269

9638

R41.0

ICD-10 Finland

Disorientation, unspecified

3.8

28.5

123

330

A04

ICPC

Weakness/tiredness general

2.0

28.3

374

1957

F25.80

ICD-10 Finland

Other specified schizoaffective disorder with only concomitant bipolar and schizophrenic symptoms

+∞

28.2

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.8

28.1

521

3087

30041

ICD-8 Finland

Neuroses, Depressiva

7.1

27.9

F15.2

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome

17.4

27.5

F33.3

ICD-10 Finland

Recurrent depressive disorder, current episode severe with psychotic symptoms

25.6

27.5

SPAT1263

SPAT

Sampling

1.6

27.3

1115

8269

EBA30

NOMESCO Finland

Excision of root of tooth

2.8

27.3

181

667

ICC03

NOMESCO Finland

Psychiatric treatment plan, transfer to psychiatric ward

30.4

27.2

P79

ICPC

Phobia/compulsive disorder

53.9

27.2

K59.09

ICD-10 Finland

Constipation, unspecified

2.8

27.2

188

709

F23.29

ICD-10 Finland

Acute schizophrenia-like psychosis UNS

+∞

27.1

N06AX12

ATC

bupropion; oral

2.7

27.1

196

762

U07.2

ICD-10 Finland

COVID-19, virus not identified

0.4

27.0

112

2711

P80

ICPC

Personality disorder

18.9

27.0

F03

ICD-10 Finland

Unspecified dementia

3.1

26.8

152

505

SPAT1249

SPAT

Treatment-related counselling outside office

1.6

26.6

1016

7396

-1

NOMESCO Finland

1.6

26.6

855

5959

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.5

26.4

219

920

F42.0

ICD-10 Finland

Predominantly obsessional thoughts or ruminations

15.6

26.4

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.5

26.3

1424

11253

F31.2

ICD-10 Finland

Bipolar affective disorder, current episode manic with psychotic symptoms

52.2

26.2

IEY06

NOMESCO Finland

Psychiatric treatment and rehabilitation coaching

52.2

26.2

F20.38

ICD-10 Finland

Undifferentiated schizophrenia other definite

+∞

26.1

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

3.2

25.9

144

472

EBA15

NOMESCO Finland

Extraction of large number of teeth

3.4

25.9

129

390

J01FA10

ATC

azithromycin; systemic

0.6

25.6

935

12252

F31.8

ICD-10 Finland

Other bipolar affective disorders

5.6

25.4

137

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

6.9

25.4

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

7.2

25.3

IHZ07

SPAT

18.0

25.2

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

8.9

25.2

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.6

25.2

732

4954

F25.81

ICD-10 Finland

Other specified schizoaffective disorder with prolonged schizophrenic than bipolar symptoms

+∞

25.0

3012C

ICD-9 Finland

Personality disorders, Schizoid personality disorder[PSYKOOSIPIIRTEINEN PERSOONALLISUUS]

+∞

25.0

F15.5

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, psychotic disorder

58.5

25.0

30180

ICD-8 Finland

Personality disorders, Immatura

17.2

24.9

30188

ICD-8 Finland

Personality disorders, Alia definita

19.7

24.7

X78

ICD-10 Finland

Intentional self-harm by sharp object

19.7

24.7

F10.51

ICD-10 Finland

Psychotic alcohol paranoia

252.3

24.7

IFC99

NOMESCO Finland

Other biological psychiatric intervention

90.9

24.7

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.2

24.6

266

1270

IBB01

NOMESCO Finland

Psychiatric functioning capacity evaluation

43.2

24.6

F42.2

ICD-10 Finland

Mixed obsessional thoughts and acts

12.4

24.5

SPAT1235

SPAT

Mental health, emotional support

12.4

24.5

C07AB07

ATC

bisoprolol; oral

1.5

24.4

1188

9106

F40.1

ICD-10 Finland

Social phobias

4.7

24.0

181

P19

ICPC

Drug abuse

8.1

23.9

SPAT1251

SPAT

Organisation of medication

3.2

23.9

131

426

SPAT1216

SPAT

Assessment of functional ability

1.8

23.8

420

2436

Z04.6

ICD-10 Finland

General psychiatric examination, requested by authority

87.5

23.7

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

3.8

23.6

102

275

P03

ICPC

Feeling depressed

2.3

23.5

237

1095

L17

ICPC

Foot/toe symptom/complaint

1.7

23.4

626

4128

SPAT1241

SPAT

Extensive assessment of psychosocial situation

6.6

23.3

Z71.8

ICD-10 Finland

Other specified counselling

1.7

23.2

604

3949

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

6.9

22.8

F60.8

ICD-10 Finland

Other specific personality disorders

10.1

22.8

SAA02

NOMESCO Finland

Basic examination of mouth

1.5

22.6

1621

13422

ICC01

NOMESCO Finland

Psychiatric treatment plan, transfer to psychiatric outpatient clinic

20.8

22.5

W0A12

NOMESCO Finland

Planned therapy visit for psychiatric disease

11.2

22.4

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

5.7

22.2

114

Z08

ICPC

Social welfare problem

5.9

22.0

107

U04

ICPC

Incontinence urine

2.8

22.0

143

522

F20.19

ICD-10 Finland

Hebefren schizophrenia UNS

+∞

21.9

G40.9

ICD-10 Finland

Epilepsy, unspecified

3.3

21.9

112

347

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

7.3

21.7

F19.25

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances continuously used

20.2

21.7

S29

ICPC

Skin symptom/complaint other

1.8

21.7

427

2562

K59.0

ICD-10 Finland

Constipation

2.6

21.5

166

670

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.4

21.5

190

824

F31.5

ICD-10 Finland

Bipolar affective disorder, current episode severe depression with psychotic symptoms

15.4

21.5

X61

ICD-10 Finland

Intentional self-poisoning by and exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere classified

15.4

21.5

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.5

21.3

1018

7702

F42.1

ICD-10 Finland

Predominantly compulsive acts [obsessional rituals]

12.4

21.3

N06AA06

ATC

trimipramine; systemic

3.8

21.3

244

F19.24

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction

19.0

21.3

F10.52

ICD-10 Finland

Psychotic alcohol hallucination

23.3

21.3

F10.23

ICD-10 Finland

Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication

10.4

21.1

F31

ICD-10 Finland

Bipolar affective disorder

6.3

21.1

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.9

21.0

361

2070

IHZ05

SPAT

5.1

20.9

135

SPAT1310

SPAT

Counselling related to known health issue

1.5

20.9

796

5715

29899

ICD-8 Finland

Other psychoses, Reactive psychosis, unspecified

60.5

20.9

9690A

ICD-9 Finland

Poisoning by psychotropic agents, Antidepressants

18.0

20.8

R1220

NOMESCO Finland

Psychological examination of need and possibilities to rehabilitation

8.7

20.6

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.1

20.6

232

1131

WX110

NOMESCO Finland

Local anesthesy

1.5

20.5

1760

14964

OAB48

SPAT

0.3

20.5

1240

N02AJ06

ATC

codeine and paracetamol; systemic

0.6

20.4

499

7192

M01AB05

ATC

diclofenac; systemic, rectal

0.7

20.3

1240

15035

G72.8

ICD-10 Finland

Other specified myopathies

5.4

20.2

115

T82

ICPC

Obesity

3.1

20.2

111

362

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

4.4

20.2

172

OAA67

SPAT

0.2

20.2

1103

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.7

20.1

475

3005

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

2.1

20.1

233

1150

SPAT1244

SPAT

Occupational therapy

6.5

20.1

F60.1

ICD-10 Finland

Schizoid personality disorder

17.4

20.0

SPAT1305

SPAT

Counselling and guidance related to physical exercise

2.0

19.9

259

1337

F06.0

ICD-10 Finland

Organic hallucinosis

20.9

19.9

Z29

ICPC

Social problem NOS

4.2

19.9

184

3049X

ICD-9 Finland

Drug dependence, Unspecified drug dependence

57.9

19.9

3000A

ICD-9 Finland

Neurotic disorders, Anxiety states[TARKEMMIN MÄÄRITTELEMÄTÖN AHDISTUNEISUUSHÄIRIÖ]

10.7

19.9

29510

ICD-8 Finland

Schizophrenia, Hebephrenic type

+∞

19.8

F20.33

ICD-10 Finland

Undifferentiated schizophrenia periodically with gradual improvement

+∞

19.8

2953A

ICD-9 Finland

Schizophrenic psychoses, Paranoid type[PARANOIDISTYYPPINEN SKITSOFRENIA,TARKEMMIN MÄÄRITTE]

+∞

19.8

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

4.0

19.7

205

F31.21

ICD-10 Finland

Bipolar disorder, manic episode with mood incongruent psychotic symptoms

74.0

19.7

N05CD02

ATC

nitrazepam; oral

4.0

19.5

202

F13.29

ICD-10 Finland

Addiction caused by sedative and hypnotic UNS

13.9

19.5

N05AA03

ATC

promazine; systemic

40.4

19.5

-50

ICPC

Medication/prescr/renewal

2.7

19.5

133

501

N05AB02

ATC

fluphenazine; systemic

11.4

19.4

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.4

19.4

168

720

F42.9

ICD-10 Finland

Obsessive-compulsive disorder, unspecified

14.7

19.4

30000

ICD-8 Finland

Neuroses, Anxiety neurosis

7.6

19.3

2961C

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,KESKIVAIKEA]

10.1

19.3

P16

ICPC

Acute alcohol abuse

4.7

19.2

144

A06AC01

ATC

ispaghula (psylla seeds); oral

1.6

19.2

623

4289

F12.1

ICD-10 Finland

Mental and behavioural disorders due to use of cannabinoids, harmful use

22.7

19.0

P18

ICPC

Medication abuse

11.4

19.0

WVA30

SPAT

3.6

18.9

238

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

4.2

18.9

179

2961D

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,VAIKEA-ASTEINEN]

10.7

18.9

IEY21

NOMESCO Finland

Other intensified psychiatric treatment

34.5

18.9

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.0

18.9

245

1263

29800

ICD-8 Finland

Other psychoses, Reactive depressive psychosis

+∞

18.8

29570

ICD-8 Finland

Schizophrenia, Schizo-affective type

+∞

18.8

N05AX16

ATC

brexpiprazole; oral

70.3

18.7

T50.9

ICD-10 Finland

Poisoning: Other and unspecified drugs, medicaments and biological substances

13.5

18.7

S10

ICPC

Boil/carbuncle

2.5

18.6

154

645

3010A

ICD-9 Finland

Personality disorders, Paranoid personality disorder

100.7

18.6

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.8

18.5

373

2250

RT150

NOMESCO Finland

25.2

18.2

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.6

18.2

133

522

F05.8

ICD-10 Finland

Other delirium

8.3

18.2

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.8

18.2

365

2199

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.5

18.1

773

5664

R07.4

ICD-10 Finland

Chest pain, unspecified

1.5

18.0

686

4895

SPAT1262

SPAT

Handing over of treatment supplies

1.7

17.9

460

2972

R4140

NOMESCO Finland

Psychotherapy

10.1

17.9

IBB02

NOMESCO Finland

Psychiatric evaluation of working capacity and rehabilitation

9.6

17.9

S21

ICPC

Skin texture symptom/complaint

1.8

17.8

306

1751

F13.25

ICD-10 Finland

Addiction caused by sedative and hypnotic continuous use

16.6

17.8

RS140

NOMESCO Finland

20.2

17.7

29710

ICD-8 Finland

Paranoid states, Involutional paraphrenia

+∞

17.7

9694A

ICD-9 Finland

Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers

8.2

17.7

Z00.0

ICD-10 Finland

General medical examination

1.6

17.7

462

2998

A01

ICPC

Pain general/multiple sites

2.1

17.7

208

1029

P58

ICPC

Psychological, Therapeutic counselling/listening

4.9

17.6

117

R02

ICPC

Shortness of breath/dyspnoea

1.8

17.6

305

1749

Z00.8

ICD-10 Finland

Other general examinations

2.1

17.2

192

930

C03CA01

ATC

furosemide; systemic

1.5

17.2

709

5142

N30.0

ICD-10 Finland

Acute cystitis

1.7

17.1

350

2118

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.9

17.0

263

1450

3094A

ICD-9 Finland

Adjustment reaction, With mixed disturbance of emotions and conduct

50.3

17.0

N05AX15

ATC

cariprazine; oral

50.3

17.0

R01AD12

ATC

fluticasone furoate; nasal

0.6

16.9

356

5334

L28

ICPC

Limited function/disability (L)

1.7

16.9

394

2477

K04.7

ICD-10 Finland

Periapical abscess without sinus

2.3

16.9

157

698

M01AE01

ATC

ibuprofen; systemic, rectal

0.7

16.8

2017

22221

GD1AA

SPAT

0.2

16.8

926

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.0

16.8

219

1132

R25.1

ICD-10 Finland

Tremor, unspecified

3.1

16.8

307

Z02.4

ICD-10 Finland

Examination for driving licence

0.6

16.8

208

3541

P45

ICPC

Psychological, Observ/health educat/advice/diet

63.7

16.7

OAA65

SPAT

0.3

16.7

1314

A46

ICD-10 Finland

Erysipelas

1.7

16.7

355

2174

F23.09

ICD-10 Finland

Acute polymorphic psychosis without actual schizophrenic disease picture UNS

+∞

16.7

F20.31

ICD-10 Finland

Undifferentiated schizophrenia periodically with gradual deterioration

+∞

16.7

F70.0

ICD-10 Finland

Mild mental retardation, With the statement of no, or minimal, impairment of behaviour

35.2

16.7

F30.20

ICD-10 Finland

Mania with mood-congruent psychotic symptoms

90.6

16.6

SPAT1053

SPAT

Memory test

1.7

16.5

355

2178

R3540

NOMESCO Finland

Rehabilitative work activities

170.9

16.5

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.2

16.5

170

796

F15.1

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, harmful use

18.0

16.4

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

10.8

16.4

F13.1

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use

10.8

16.4

F19.9

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, unspecified mental and behavioural disorder

20.2

16.4

N06AX05

ATC

trazodone; oral

3.2

16.4

273

S22

ICPC

Nail symptom/complaint

2.3

16.3

156

705

Z72.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3009466) Valproate [Moles/volume] in Serum or Plasma

302

252

13.18

305.75

6.7

4.2

umol/l

374.0

349.6

1.44

276

217

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

144

18.15

177.45

13.2

8.3

mmol/l

0.6

0.11

132

(3028707) Methadone [Presence] in Urine by Screen method

225

316

7.60

153.21

4.8

3.3

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

770

2998

3.09

144.55

2.5

1.7

1.6

1.4

5.01

694

2666

(3019309) Folate [Moles/volume] in Red Blood Cells

958

4405

2.71

130.07

2.0

1.7

nmol/l

1185.9

1170.1

0.21

751

3308

(4198724)

105

16.44

123.67

3.2

4.6

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1333

7881

2.22

97.40

3.7

3.2

u/l

32.2

36.6

0.92

1258

7482

(3011288) Drugs identified in Urine by Screen method

223

524

4.51

87.35

6.6

3.3

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

242

635

4.05

81.87

4.7

2.4

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1491

9739

2.03

78.61

2.4

2.0

pmol/l

94.7

95.3

0.19

807

4972

(3021960) Folate [Moles/volume] in Serum or Plasma

965

5435

2.13

75.51

1.7

1.5

nmol/l

19.1

20.6

2.56

858

4651

(3016879) Cocaine [Presence] in Urine

257

782

3.49

69.85

4.8

2.3

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

1282

8211

1.96

68.73

2.8

3.4

mmol/l

2.4

0.06

1110

7186

(3000764) Benzodiazepines [Presence] in Urine

263

837

3.34

66.53

4.8

2.2

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

887

5051

2.06

65.84

1.8

1.7

pmol/l

27534702.2

25298476.0

0.05

730

4194

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1693

12021

1.91

65.37

6.3

6.6

mmol/l

1.2

2.36

1411

10144

(3027008) Opiates [Presence] in Urine

261

844

3.29

64.29

4.8

1.9

—

(3028300) Cannabinoids [Presence] in Urine

261

847

3.27

63.91

4.9

2.2

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1562

10866

1.89

63.61

5.9

mmol/l

1.2

1.82

1436

9823

(3027944) Amphetamines [Presence] in Urine

254

825

3.27

62.07

4.7

2.1

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2300

18487

1.97

56.39

5.1

4.0

pmol/l

14.9

14.8

0.42

2120

16854

(3013650) Neutrophils [#/volume] in Blood by Automated count

1857

13967

1.83

55.81

20.3

8.3

e9/l

4.3

4.1

5.38

1633

12170

(3018418) pH of Serum or Plasma

1106

7109

1.87

55.64

3.7

4.0

7.4

0.20

195

1363

(3013115) Eosinophils [#/volume] in Blood

1691

12474

1.79

53.07

10.5

5.7

e9/l

0.2

2.56

1473

10944

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2316

18813

1.94

52.93

7.0

7.5

u/l

80.6

78.0

1.06

2167

17694

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

+∞

52.23

5.7

0.0

—

(3006315) Basophils [#/volume] in Blood

1641

12051

1.78

51.79

8.6

5.6

e9/l

0.0

1.90

1410

10428

(3001604) Monocytes [#/volume] in Blood

1634

12011

1.77

51.14

8.4

5.6

e9/l

0.6

2.59

1398

10385

(3026008) Bacteria identified in Urine by Culture

1094

7151

1.82

51.13

3.6

3.3

—

(3019198) Lymphocytes [#/volume] in Blood

1658

12368

1.74

48.07

8.9

5.7

e9/l

2.0

1.9

0.59

1430

10902

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1130

7569

1.78

47.90

2.6

u/l

52.5

57.9

3.59

1032

6996

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1403

9998

1.74

47.84

2.5

2.2

nmol/l

72.6

77.6

8.77

1276

8996

(3021387) Prolactin [Units/volume] in Serum or Plasma

205

706

3.04

45.13

1.9

1.6

mu/l

581.5

267.4

7.85

177

645

(3024561) Albumin [Mass/volume] in Serum or Plasma

1445

10503

1.71

44.91

4.1

4.8

g/l

35.2

35.6

2.29

1316

9789

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1081

7365

1.72

41.77

2.6

2.1

u/l

353.5

217.7

2.50

1002

6911

(3031040) Bacteria [#/volume] in Urine by Automated count

1963

15686

1.70

41.15

6.0

4.5

e6/l

5668.5

1695.1

1.16

213

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2566

22193

1.95

40.48

6.6

4.7

mu/l

1.9

2.1

0.77

2391

20346

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

656

3888

1.87

40.47

1.9

1.8

—

(42870588) Differential panel, method unspecified - Blood

1158

8109

1.69

39.98

6.9

5.8

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1645

12609

1.66

39.96

5.1

6.2

umol/l

10.0

11.6

3.51

1540

11963

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2050

16658

1.69

39.46

4.4

3.1

u/l

46.1

49.8

1.29

1899

15575

(3022096) Basophils/100 leukocytes in Blood

1466

10962

1.64

38.88

9.1

5.9

0.6

0.7

7.82

1359

10238

(3019069) Monocytes/100 leukocytes in Blood

1504

11339

1.64

38.44

9.4

6.1

8.4

8.7

2.47

1399

10619

(3006504) Eosinophils/100 leukocytes in Blood

1491

11283

1.62

37.03

8.8

5.8

2.5

2.9

8.65

1384

10522

(3009508) Creatinine [Moles/volume] in Urine

1053

7352

1.66

35.80

3.9

3.2

mmol/l

7.2

7.6

1.68

908

6188

(21494755) Public health laboratory ask at order entry panel

2634

0.23

35.79

1.3

1.4

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

1785

14193

1.61

35.55

5.2

4.7

mmol/l

6.9

6.7

1.19

1654

13328

(44816559) Phosphatidylethanol [Mass/volume] in Blood

139

438

3.28

35.50

1.5

1.3

—

(3042517) Benzodiazepines panel - Urine

15.93

34.88

3.5

2.4

—

(40758558) Short blood count panel - Blood

899

6057

1.68

34.87

12.2

6.3

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

11.00

34.67

1.8

2.4

umol/l

18.2

16.1

0.38

(3023368) Bacteria identified in Blood by Culture

949

6500

1.67

34.49

4.3

4.2

—

(3002030) Lymphocytes/100 leukocytes in Blood

1518

11663

1.60

34.48

8.9

5.9

27.4

27.9

0.91

1407

10872

(3019150) Specific gravity of Urine by Refractometry

777

5066

1.71

33.90

5.9

4.1

kg/l

1.0

0.22

110

729

(3018010) Neutrophils/100 leukocytes in Blood

1488

11488

1.57

32.31

9.0

5.7

58.3

57.3

2.80

1380

10756

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

472

2692

1.89

32.14

1.9

1.7

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

472

2700

1.88

31.83

1.9

1.7

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

2404

0.26

29.49

1.6

1.7

—

(3037467) Urinalysis macro (dipstick) panel - Urine

1971

16569

1.53

26.62

5.0

4.3

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

674

4500

1.64

25.86

2.8

3.1

mmol/l

2.4

2.5

0.75

575

3959

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

+∞

25.03

1.9

0.0

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

272

1398

2.04

24.82

1.7

1.5

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

232

3.60

24.80

2.3

1.5

—

(1761868) Lipid panel - Serum or Plasma

636

9114

0.62

24.77

3.4

2.7

—

(3015736) pH of Urine

1188

9117

1.49

24.15

4.7

3.4

—

5.6

—

(3017509) Phencyclidine [Presence] in Urine

13.84

23.65

3.0

1.1

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

188

3.84

23.65

1.6

1.4

promille

0.8

1.3

2.26

142

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

830

5939

1.54

23.35

2.3

2.2

mg/l

2.8

3.0

1.02

714

5032

(3023183) Ammonium ion [Moles/volume] in Plasma

126

480

2.69

22.99

2.0

3.1

umol/l

32.0

38.0

1.34

103

409

(3019550) Sodium [Moles/volume] in Serum or Plasma

2736

25176

1.79

22.26

21.9

15.9

mmol/l

139.5

139.6

2.04

2675

24526

(3044889) 12 lead EKG panel

1999

17144

1.47

22.18

4.7

3.7

—

(3026782) Osmolality of Urine

680

4728

1.56

21.49

2.7

mosm/kgh2o

485.6

546.2

9.16

568

4006

(3029937) Albumin [Presence] in Urine by Test strip

854

6253

1.51

21.22

5.2

4.1

estimate

0.0

1.28

268

2123

(3023103) Potassium [Moles/volume] in Serum or Plasma

2737

25268

1.76

20.93

21.8

16.1

mmol/l

4.0

0.28

2671

24580

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

129

4.24

20.70

1.7

1.3

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1603

0.26

19.98

1.4

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

4.84

19.88

3.8

4.0

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

2383

0.40

19.25

1.5

1.4

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

353

2172

1.71

18.05

3.1

3.5

kpa

6.0

5.8

1.91

332

2109

(3023511) Choriogonadotropin [Units/volume] in Urine

260

3.01

17.61

1.8

1.2

—

(3002032) Base excess in Venous blood by calculation

348

2147

1.70

17.60

3.1

3.5

mmol/l

2.5

2.0

1.65

277

1740

(3002582) Erythrocytes [#/volume] in Urine

940

7235

1.43

17.37

3.5

3.2

e6/l

46.4

78.9

1.03

722

5529

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

4.47

17.28

2.7

1.9

umol/l

88.1

183.0

1.06

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

123

536

2.35

16.96

2.1

2.3

u/l

4384.4

3379.2

0.13

210

(3021589) Normoblasts [#/volume] in Blood

1300

10615

1.39

16.96

11.5

9.4

e9/l

0.0

0.91

1051

8695

(3020682) Albumin/Creatinine [Ratio] in Urine

942

7283

1.42

16.88

3.9

mg/mmol

7.1

9.3

0.96

590

4552

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

833

6313

1.44

16.62

1.7

1.6

mmol/l

1.7

1.4

10.19

732

5339

(3003181) Sodium [Moles/volume] in Urine

105

431

2.49

16.52

1.2

1.3

mmol/l

57.5

60.9

0.39

344

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

251

1438

1.81

16.42

2.0

1.6

—

(3000850) Epithelial cells [#/volume] in Urine

687

5043

1.47

16.16

2.9

2.5

e6/l

6.9

5.7

1.40

600

4413

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

240

1363

1.83

16.15

3.3

3.4

mmol/l

2.5

1.7

1.90

189

1012

(3014111) Lactate [Moles/volume] in Serum or Plasma

338

2119

1.67

16.04

5.0

6.8

mmol/l

1.5

1.4

0.91

318

2040

(3012516) Albumin [Mass/volume] in Urine

895

6916

1.41

15.89

3.3

3.2

mg/l

483.3

378.2

0.23

564

4334

(3001019) Free T4 and TSH panel - Serum or Plasma

1316

0.27

15.81

1.4

1.7

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

249

1440

1.79

15.78

3.3

3.4

kpa

5.3

5.2

1.98

230

1327

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2468

22579

1.47

15.70

7.2

5.5

mmol/mol

40.2

39.8

1.44

2282

20928

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2562

23628

1.51

15.52

6.1

4.4

mmol/l

6.2

5.9

18.11

2367

21563

(3008295) Osmolality of Serum or Plasma

252

2.90

15.49

1.3

mosm/kgh2o

279.9

278.1

0.20

186

(3012095) Magnesium [Moles/volume] in Serum or Plasma

548

3876

1.50

15.44

2.5

3.4

mmol/l

0.8

2.25

494

3616

(3009343) pH of Capillary blood

245

1421

1.79

15.37

3.4

3.5

7.4

0.39

181

(3018095) Leukocytes [#/volume] in Urine

1055

8422

1.38

15.35

4.2

3.6

e6/l

88.8

103.9

0.23

763

5967

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1150

9382

1.36

14.36

4.6

3.6

ng/l

44.1

41.5

0.09

837

6304

(3024354) Oxygen [Partial pressure] in Venous blood

287

1784

1.67

14.03

2.7

2.8

kpa

4.9

4.6

1.37

274

1727

(3008152) Bicarbonate [Moles/volume] in Arterial blood

249

1492

1.73

13.94

7.6

7.1

mmol/l

25.6

24.3

5.00

239

1380

(3030467) Casts [#/volume] in Urine by Automated count

851

6649

1.39

13.79

3.4

3.1

e6/l

0.4

0.5

0.40

644

5000

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

4.66

13.52

2.8

2.7

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

4.66

13.52

2.8

2.7

—

(3003396) Base excess in Arterial blood by calculation

400

2720

1.54

13.44

6.6

7.4

mmol/l

2.0

1.0

6.04

325

2100

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

239

1436

1.72

13.25

2.3

3.4

pmol/l

4.4

4.5

1.22

199

1275

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

7.87

13.15

1.3

1.1

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

119

580

2.09

12.56

4.2

3.0

mmol/l

26.1

24.9

1.79

105

505

(36304419) Bacteria [Presence] in Urine

827

6522

1.37

12.42

3.4

3.0

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

712

5483

1.39

12.38

4.6

3.7

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

153

822

1.91

12.28

2.1

2.3

ug/l

498.0

453.4

0.09

143

772

(3014576) Chloride [Moles/volume] in Serum or Plasma

428

3011

1.49

12.18

5.7

6.8

mmol/l

103.7

104.3

1.51

404

2947

(3016502) Oxygen saturation in Arterial blood

357

2425

1.53

12.00

6.7

7.9

94.7

95.8

2.97

347

2328

(3036481) Cortisol [Moles/volume] in Serum or Plasma

333

2230

1.55

11.94

1.8

2.1

nmol/l

390.9

374.4

0.71

304

2033

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

629

4770

1.40

11.93

4.2

3.7

ng/l

227.6

411.3

1.41

454

3693

(3035350) Ketones [Presence] in Urine by Test strip

1376

11757

1.31

11.73

4.6

3.7

estimate

0.0

0.00

258

2168

(3002173) Hemoglobin [Mass/volume] in Arterial blood

333

2248

1.54

11.50

6.8

8.3

g/l

124.1

122.0

1.07

321

2157

(3028626) Oxygen [Partial pressure] in Capillary blood

103

492

2.13

11.48

3.2

2.8

kpa

8.0

8.1

0.43

450

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

391

2732

1.49

11.48

6.7

7.4

kpa

5.4

5.1

5.63

371

2599

(3003458) Phosphate [Moles/volume] in Serum or Plasma

434

3104

1.46

11.32

4.5

5.9

mmol/l

1.0

1.49

394

2876

(3027801) Oxygen [Partial pressure] in Arterial blood

390

2732

1.49

11.30

6.7

7.4

kpa

10.7

12.5

11.47

370

2599

(3026389) Candida sp identified in Specimen by Organism specific culture

304

2.44

11.24

1.5

1.4

—

(3021901) Oxygen saturation in Capillary blood

411

2.23

11.23

3.3

2.8

—

(3009261) Glucose [Presence] in Urine by Test strip

1387

11925

1.30

11.06

4.5

3.7

estimate

0.0

1.32

264

2133

(3002385) Erythrocyte distribution width [Ratio]

2217

20320

1.33

10.76

27.9

16.5

13.8

13.7

4.60

2167

19856

(3021601) Nitrite [Presence] in Urine by Test strip

1370

11801

1.29

10.61

5.7

5.0

estimate

0.0

0.50

275

2205

(3000991) Gas panel - Venous blood

292

1957

1.54

10.41

6.0

8.2

—

(3032080) INR in Blood by Coagulation assay

1150

9720

1.29

10.19

8.2

9.1

inr

1.2

1.86

371

2775

(3044242) Glucose [Moles/volume] in Arterial blood

118

3.25

10.12

1.6

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

376

2675

1.46

10.03

1.7

1.6

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

851

6946

1.31

9.70

3.0

ng/l

1163.2

1492.0

1.99

685

5899

(40760892) CBC W Ordered Manual Differential panel - Blood

676

5352

1.34

9.53

8.0

4.2

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

327

2287

1.48

9.51

2.9

2.4

u/l

28.2

60.8

0.94

293

1987

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

182

1115

1.67

9.42

3.3

3.5

mmol/l

24.6

24.2

0.79

151

1020

(3027273) Bicarbonate [Moles/volume] in Venous blood

181

1113

1.67

9.24

2.7

3.4

mmol/l

26.3

25.2

2.54

172

1079

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

301

2101

1.48

8.83

2.6

2.4

ug/l

6.0

7.2

0.45

243

1839

(3027945) Reticulocytes/100 erythrocytes in Blood

362

2618

1.43

8.82

2.7

2.5

1.8

0.22

311

2316

(3004119) Hemoglobin [Mass/volume] in Venous blood

218

1422

1.57

8.77

2.4

3.1

g/l

131.6

129.1

0.90

212

1387

(3019060) Gas panel - Arterial blood

236

1569

1.55

8.73

5.7

5.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

298

4159

0.69

8.62

2.3

2.8

ug/l

0.6

0.7

3.93

209

2495

(3039443) Prostate specific Ag panel - Serum or Plasma

547

0.18

8.61

1.2

1.6

—

(3040151) Glucose [Moles/volume] in Capillary blood

255

2.34

8.46

12.8

5.5

mmol/l

7.3

7.4

0.09

223

(3047181) Lactate [Moles/volume] in Blood

129

741

1.77

8.45

7.5

6.8

mmol/l

1.3

0.08

114

637

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

154

2.75

8.44

1.0

ng/l

697.0

724.0

0.15

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

284

1978

1.48

8.42

3.0

3.8

mmol/l

1.2

0.74

240

1720

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

155

2.73

8.34

1.0

ng/l

338.5

298.3

0.34

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

155

2.73

8.34

1.0

ng/l

42.3

42.7

0.02

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

174

1090

1.63

8.29

2.4

2.5

0.7

0.35

161

1050

(3000494) Fungus identified in Specimen by Culture

383

2829

1.40

8.28

1.4

1.5

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

294

2077

1.46

8.11

2.1

1.9

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1066

9119

1.26

8.06

5.0

3.9

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

446

3393

1.37

8.06

2.2

2.5

g/l

2.4

2.3

0.70

395

3136

(3017181) Myelocytes/100 leukocytes in Blood

283

2005

1.45

7.69

6.5

3.9

0.9

0.12

554

(1616796) Gas panel - Central venous blood

519

1.88

7.68

3.5

3.6

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

4.74

7.63

1.8

1.4

—

(40768804) Tissue Pathology biopsy report

824

9741

0.79

7.55

2.0

2.1

—

(3043409) Potassium [Moles/volume] in Arterial blood

124

730

1.73

7.49

3.7

4.0

mmol/l

3.8

3.9

1.16

103

687

(3013707) Erythrocyte sedimentation rate by Westergren method

1968

18095

1.24

7.49

3.9

4.1

mm/h

13.3

12.1

2.72

1792

16791

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

368

2749

1.38

7.42

2.4

2.8

umol/l

6.1

8.1

1.76

299

2409

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

517

4070

1.32

7.41

3.0

2.7

e6/l

1.6

1.2

0.91

281

2276

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

486

3796

1.33

7.35

3.1

2.8

e6/l

5.0

2.5

3.35

244

2018

(46235355) HIV 1 and 2 tests - Meaningful Use set

501

3937

1.33

7.26

2.2

1.8

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

217

2.33

7.16

1.1

1.6

—

(3020779) Urea [Moles/volume] in Serum or Plasma

290

2098

1.42

7.04

4.9

7.9

mmol/l

9.5

9.7

0.17

275

2003

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

246

1733

1.46

6.90

1.5

1.6

—

(3020891) Body temperature

151

965

1.59

6.68

4.8

4.3

—

(3007853) Bacteria identified in Skin by Aerobe culture

365

2771

1.36

6.65

1.9

1.7

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2588

24688

1.31

6.62

18.5

14.0

mg/l

22.9

23.7

0.65

2182

19545

(3016038) Potassium [Moles/volume] in Urine

151

2.54

6.60

1.2

mmol/l

20.4

33.4

3.74

131

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

111

2.81

6.57

3.0

2.5

—

(3021440) Promyelocytes/100 leukocytes in Blood

264

1918

1.41

6.27

6.8

3.9

0.1

1.12

509

(3022948) Iron [Moles/volume] in Serum or Plasma

465

3694

1.30

6.19

2.3

2.5

umol/l

11.5

13.3

6.76

425

3419

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

461

1.82

6.17

1.3

1.2

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

384

1.90

6.08

1.2

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

133

845

1.60

6.06

1.6

2.1

—

(3022217) INR in Platelet poor plasma by Coagulation assay

400

3122

1.32

6.04

24.2

24.5

inr

1.3

0.17

435

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

531

1.76

6.03

1.1

1.3

mmol/l

3.9

3.8

0.75

497

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

531

1.76

6.03

1.1

1.4

e6/l

13.5

31.0

0.70

411

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

531

1.76

6.03

1.2

1.5

e6/l

396.0

1472.2

0.98

433

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

307

2305

1.37

6.00

2.1

2.0

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

118

732

1.64

5.93

1.6

1.3

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

101

603

1.70

5.88

1.2

1.3

mg/l

451.0

531.0

2.10

570

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

309

4028

0.74

5.79

1.2

u/ml

17.1

12.0

0.35

1595

(3052851) Hemolysis interference index of Serum or Plasma

117

733

1.62

5.67

2.7

3.3

—

(3002179) Metamyelocytes/100 leukocytes in Blood

251

1843

1.39

5.62

5.2

3.7

0.6

0.17

406

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

382

2993

1.32

5.61

9.6

7.0

—

(3022313) Gas panel - Capillary blood

155

1040

1.52

5.58

3.5

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

184

1283

1.46

5.49

9.0

10.4

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

16.04

5.41

1.3

1.2

nmol/l

292.1

545.9

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

388

1.82

5.29

1.2

1.1

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

331

4220

0.76

5.29

1.3

iu/ml

45.9

33.9

0.46

1366

(40761535) Cells panel - Urine sediment

262

1966

1.36

5.16

4.4

3.5

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

297

2279

1.34

5.05

2.0

2.2

g/l

0.2

0.63

267

2131

(3014271) Vancomycin [Susceptibility]

122

2.47

5.03

3.0

2.9

—

(3025159) Blasts/100 leukocytes in Blood

242

1803

1.37

4.99

7.2

3.9

0.2

0.5

0.50

430

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

322

2509

1.32

4.92

4.9

3.4

—

(1002224) Polysomnography panel

1149

0.57

4.91

1.0

1.1

—

(40768800) Prostate Pathology biopsy report

390

0.28

4.89

1.0

1.2

—

(3002256) Pathology report gross observation

229

3045

0.73

4.89

1.3

—

(3000034) Microalbumin [Mass/volume] in Urine

208

2.08

4.84

3.4

3.0

mg/l

39.2

42.0

0.05

156

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

157

1090

1.46

4.82

1.9

2.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

163

2.22

4.78

1.1

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1131

10136

1.18

4.69

2.7

ug/l

112.6

131.0

2.45

1021

9379

(40761536) Microorganisms panel - Urine sediment

264

2015

1.34

4.67

4.4

4.1

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

394

3182

1.27

4.59

2.3

2.5

19.4

23.2

6.72

321

2713

(3026493) Urate [Moles/volume] in Serum or Plasma

549

6486

0.81

4.57

2.2

2.6

umol/l

780.4

5505.9

9.87

437

5657

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

359

0.28

4.57

1.4

1.5

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2715

26298

1.28

4.51

12.1

10.2

u/l

27.6

27.2

0.55

2631

25415

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

2.59

4.47

2.7

2.5

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

518

1.64

4.41

2.4

2.1

g/l

128.5

130.5

0.26

371

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

130

887

1.49

4.39

3.2

3.7

mmol/l

25.1

24.8

0.38

119

817

(3003694) ABO and Rh group [Type] in Blood

543

6388

0.82

4.31

1.3

1.4

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

139

973

1.45

4.14

6.6

5.5

1.9

1.6

1.69

133

903

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

338

0.29

4.13

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

338

0.29

4.13

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

337

0.29

4.11

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

337

0.29

4.11

1.4

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

2707

26264

1.26

4.06

20.6

16.0

umol/l

76.6

77.7

1.07

2707

26256

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

129

899

1.45

3.95

2.1

1.8

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

105

703

1.51

3.92

1.3

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

178

2.03

3.89

1.1

1.3

mmol/l

2.4

2.0

0.41

167

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

263

2064

1.30

3.85

3.1

3.0

ng/l

197.7

201.5

0.05

246

1860

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

385

3168

1.25

3.83

1.8

1.6

—

(3007463) Buprenorphine [Presence] in Urine

8.77

3.77

5.7

10.5

—

(3000492) Spirometry study

192

2518

0.75

3.76

1.5

—

(3035637) Corticotropin [Mass/volume] in Plasma

269

1.80

3.61

1.5

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

135

967

1.41

3.59

6.8

5.6

0.9

0.18

130

899

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1014

11161

0.86

3.57

3.9

—

(4010399)

215

1662

1.32

3.54

1.4

—

(3010421) pH of Blood

663

1.49

3.52

4.0

3.9

7.4

0.37

549

(3044290) Cell count panel - Cerebral spinal fluid

480

1.58

3.46

1.1

1.4

—

(3002523) Influenza virus A Ag [Presence] in Specimen

434

0.43

3.44

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

433

0.44

3.43

1.1

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

601

5224

1.19

3.42

1.3

1.2

u/ml

2.1

1.7

0.24

150

1405

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

626

5467

1.18

3.37

1.7

1.8

mg/l

1.1

0.04

484

4124

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

225

1.83

3.32

2.0

1.6

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

3.58

3.19

1.2

1.0

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

135

989

1.38

3.19

2.1

1.9

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

288

1.71

3.17

1.5

1.4

u/l

32.5

28.0

0.33

230

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

164

1240

1.34

3.17

7.1

9.6

mmol/l

24.8

24.4

1.11

140

1165

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

615

0.55

3.14

1.4

1.5

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

288

0.35

3.11

1.4

1.5

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

361

1.62

3.04

1.4

1.7

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

128

941

1.38

2.98

2.1

2.0

ug/l

1.3

1.8

0.35

110

824

(3009214) Lutropin [Units/volume] in Serum or Plasma

639

1.45

2.95

1.4

u/l

10.5

8.9

0.45

519

(3047352) Trisomy 18 risk [Likelihood] in Fetus

279

0.36

2.92

1.4

—

(3023520) Reticulocytes [#/volume] in Blood

240

1942

1.26

2.81

1.8

2.6

e9/l

70.3

69.9

0.05

171

1466

(3008401) Mugwort IgE Ab [Units/volume] in Serum

385

0.46

2.80

1.1

u/ml

0.3

1.6

—

161

(3024928) Oxygen saturation in Venous blood

507

1.49

2.77

1.7

2.7

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

3.23

2.77

1.2

1.0

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

166

1.88

2.76

1.1

1.0

—

(3012501) Base excess in Blood by calculation

557

1.47

2.75

4.3

4.2

mmol/l

3.3

2.6

1.52

374

(3008898) HLA-B27 [Presence]

858

0.65

2.72

1.0

1.1

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

167

0.30

2.68

1.6

1.4

—

1.5

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

299

2492

1.22

2.68

1.6

—

(3005033) Fetal Nuchal fold Thickness US

278

0.39

2.62

1.4

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

100

2.11

2.58

1.1

1.4

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

907

0.67

2.58

1.5

1.7

mg/l

4.2

3.8

0.11

645

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

3.61

2.57

4.4

2.5

u/field

0.6

0.9

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

509

1.46

2.54

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

509

1.46

2.54

1.3

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

231

1.70

2.52

2.3

2.5

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.27

2.50

1.1

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

230

1881

1.24

2.48

3.9

3.7

ng/l

94.3

88.3

0.41

195

1619

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

488

1.47

2.46

3.1

3.7

59.5

57.1

0.82

488

(3033658) Prothrombin time (PT) actual/Normal

692

6230

1.14

2.45

4.0

3.9

91.2

90.3

0.43

663

6081

(3006653) Thiamine [Moles/volume] in Blood

123

1.96

2.45

1.0

1.3

nmol/l

160.6

135.9

1.16

123

(4035726)

168

2107

0.79

2.42

1.3

1.4

—

(3007566) Smooth muscle Ab [Titer] in Serum

675

1.39

2.40

1.2

1.3

titre

78.3

89.1

0.25

(3050129) First trimester maternal screen panel - Serum or Plasma

401

0.52

2.39

1.6

1.5

—

(3052592) Norovirus Ag [Presence] in Stool

2.61

2.35

1.1

1.4

—

(36660697) Celiac disease serology panel - Serum

224

1840

1.23

2.34

1.2

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

389

1.50

2.28

1.2

1.3

—

(3001556) Androgen free Index in Serum or Plasma

3.48

2.27

1.9

1.2

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

390

1.50

2.26

1.2

u/l

20.6

43.2

1.32

330

(3025941) Bacteria identified in Stool by Culture

172

1382

1.26

2.20

1.4

1.2

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

101

756

1.35

2.18

2.4

2.8

—

(40767503) Oxygen content in Capillary blood by calculation

502

1.42

2.16

3.4

2.4

16.4

16.5

0.04

249

(3005322) IgE [Units/volume] in Serum or Plasma

117

1511

0.77

2.15

1.2

1.3

u/ml

352.9

237.5

0.27

106

1397

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

449

0.58

2.14

1.2

1.1

u/ml

0.3

1.7

2.65

178

(3003888) Timothy IgE Ab [Units/volume] in Serum

398

0.55

2.13

1.0

1.1

u/ml

1.6

5.1

1.75

200

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

745

1.34

2.08

1.3

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

176

0.40

2.02

1.0

1.1

—

(3045716) Anion gap in Serum or Plasma

118

1.87

2.01

1.5

2.2

mmol/l

8.3

9.6

0.68

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

152

1224

1.25

1.94

1.0

1.1

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

2.73

1.93

2.4

2.3

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

157

1.73

1.92

1.1

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

157

1.73

1.92

1.1

1.0

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

219

1.60

1.90

1.1

1.0

—

(4094501)

699

0.68

1.90

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

106

1.89

1.90

2.6

3.5

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

166

1.69

1.87

1.3

mmol/l

16.2

12.5

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

751

1.31

1.85

1.3

1.1

—

(3019225) pH of Specimen

281

2420

1.18

1.83

4.2

4.3

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

301

0.53

1.81

1.3

1.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.58

1.80

2.4

2.3

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

690

0.69

1.79

2.1

2.0

mg/l

11.8

11.0

0.29

637

(3051387) C reactive protein [Mass/volume] in Capillary blood

521

1.37

1.79

4.6

3.8

mg/l

26.3

25.8

0.05

329

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

165

0.42

1.78

4.1

1.9

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

157

1283

1.24

1.78

2.4

—

(42529406) Shigella sp [Presence] in Stool by Culture

756

1.31

1.78

1.3

1.1

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

375

0.58

1.77

1.0

1.1

—

10.8

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

124

1.78

1.75

1.0

1.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

2.23

1.73

2.8

3.1

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

191

0.47

1.72

1.9

1.7

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.67

1.72

1.3

1.1

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.14

1.71

1.0

1.2

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

299

1.48

1.70

1.5

2.3

mg/l

37.4

24.3

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

207

1751

1.20

1.68

1.6

1.5

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1511

15783

0.92

1.67

3.0

2.9

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

284

1.49

1.66

1.1

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

371

4170

0.87

1.66

1.5

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

2.58

1.66

9.9

mmol/l

7.1

6.0

—

(3019832) Treponema pallidum Ab [Presence] in Serum

206

1745

1.19

1.65

1.7

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

500

0.66

1.64

2.4

3.6

u/ml

348.1

896.8

0.48

464

(3042936) Bacteria identified in Isolate by Culture

381

3389

1.14

1.63

2.1

2.0

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

3.58

1.61

1.6

1.9

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

3.58

1.61

4.2

4.9

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

183

1539

1.20

1.59

1.2

iu/ml

71.5

148.2

4.00

568

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

3.00

1.58

1.0

1.3

u/l

6.8

13.3

—

(3045424) Erythrocytes [Presence] in Urine

406

1.39

1.56

1.4

1.5

—

(3000330) Specific gravity of Urine by Test strip

1212

0.79

1.55

3.6

3.5

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.00

1.52

0.0

1.0

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

271

0.55

1.52

1.3

1.2

—

(3028717) Thiamine [Mass/volume] in Blood

2.60

1.51

1.0

1.2

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

2.16

1.50

1.2

1.3

—

(3041096) Erythrocytes [Presence] in Urine by Automated

698

6464

1.10

1.50

3.9

3.4

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

534

5830

0.90

1.48

2.2

2.3

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

755

0.74

1.48

1.7

2.1

96.4

92.1

0.61

705

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

766

0.74

1.48

1.5

1.6

iu/ml

0.2

7.9

0.50

158

(3017732) Neutrophils [#/volume] in Blood

196

1673

1.18

1.47

9.5

2.6

e9/l

4.1

0.22

147

1312

(3010726) Horse dander IgE Ab [Units/volume] in Serum

366

0.63

1.45

1.0

1.1

u/ml

0.5

2.0

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

3.13

1.44

1.0

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

636

0.72

1.43

1.1

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

682

0.73

1.43

2.3

2.4

215.3

185.8

1.16

652

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

413

1.36

1.43

1.7

1.6

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

658

0.73

1.42

1.2

1.3

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

1.82

1.41

2.8

2.7

umol/l

26.9

29.0

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2528

24801

1.11

1.41

5.7

4.7

mmol/l

2.6

2.8

14.22

2317

22906

(3048689) Calprotectin [Mass/mass] in Stool

331

2952

1.14

1.39

1.8

2.3

ug/g

130.6

141.5

0.27

243

2372

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

735

0.74

1.39

1.3

1.8

—

(40761511) CBC panel - Blood by Automated count

2611

25666

1.11

1.38

18.9

13.0

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

2.20

1.37

1.0

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.61

1.36

1.2

1.1

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

2.94

1.36

1.2

1.4

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

135

1.63

1.35

1.0

1.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

1.76

1.34

2.7

2.4

—

(3004809) Band form neutrophils/100 leukocytes in Blood

375

1.37

1.34

2.9

3.7

1.6

1.4

0.14

293

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.04

1.32

1.1

1.2

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

2.50

1.30

5.3

5.8

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

860

0.77

1.28

1.8

2.4

g/l

9.9

10.3

0.31

729

(3023410) Appearance of Cerebral spinal fluid

243

1.45

1.27

1.3

1.6

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

400

0.67

1.26

1.1

1.7

g/l

0.6

0.8

0.47

303

(4062490)

242

0.58

1.26

1.1

1.4

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

116

0.43

1.25

2.0

2.7

u/ml

1237.2

1117.3

—

116

(3013512) EKG study

741

6941

1.09

1.24

4.4

3.8

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

350

0.65

1.23

1.2

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

1097

0.81

1.23

1.8

1.9

u/l

36.6

39.5

0.85

984

(3000012) Reticulocyte production index

108

1.67

1.22

1.1

1.6

—

(3020393) Adenovirus Ag [Presence] in Stool

2.63

1.21

1.0

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2386

23398

1.09

1.18

4.5

3.9

mmol/l

1.5

1.3

18.19

2156

21480

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

127

1067

1.20

1.18

1.4

1.8

g/l

1.8

1.5

1.71

115

921

(3000570) Elastase.pancreatic [Mass/mass] in Stool

713

1.24

1.17

1.4

ug/g

269.7

285.9

0.31

399

(4146454)

265

1.40

1.16

2.3

2.8

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

197

0.56

1.14

1.1

1.2

—

188.3

—

(3009542) Hematocrit [Volume Fraction] of Blood

2234

22799

0.93

1.13

25.9

14.5

39.6

40.1

1.53

1311

16759

(3014133) Dog dander IgE Ab [Units/volume] in Serum

318

0.66

1.11

1.0

1.1

u/ml

5.5

2.6

0.50

126

(3005570) Glucose [Moles/volume] in Urine

234

1.41

1.10

1.6

2.0

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

244

0.61

1.09

1.0

1.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

137

0.51

1.09

1.4

1.1

—

(3017569) Oxygen content in Arterial blood

104

1.64

1.09

1.8

1.7

—

(3044640) Blood type and Crossmatch panel - Blood

714

7580

0.92

1.09

2.3

2.4

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

112

1.61

1.08

1.0

1.7

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

479

0.73

1.08

1.2

—

2.2

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

401

3679

1.10

1.07

1.7

2.1

29.6

29.9

0.42

378

3558

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

924

0.81

1.06

2.2

2.4

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

924

0.81

1.06

2.2

2.4

g/l

7.5

7.4

0.32

693

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

923

0.81

1.05

2.2

2.4

g/l

3.9

3.8

0.11

661

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

179

0.56

1.05

1.2

—

2.8

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

125

0.48

1.04

1.0

1.1

—

(3006576) Bicarbonate [Moles/volume] in Blood

1.74

1.02

2.8

7.6

mmol/l

27.1

24.7

1.27

(3016018) Differential panel - Cerebral spinal fluid

247

1.38

1.01

1.1

1.4

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.89

1.01

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.89

1.01

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

1.89

1.01

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.89

1.01

1.0

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

106

0.47

1.01

1.0

1.7

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

189

0.58

1.00

1.2

1.1

—

56.0

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

2.00

1.00

2.1

3.2

umol/l

37.9

39.0

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

297

0.67

0.99

1.1

u/ml

9.1

3.6

—

121

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

503

1.26

0.99

1.3

2.0

nmol/l

0.8

0.02

419

(3023323) Follitropin [Units/volume] in Serum or Plasma

114

969

1.18

0.97

1.4

1.3

iu/l

24.1

30.0

1.27

824

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.97

0.0

2.1

—

1.6

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.95

0.97

1.0

1.2

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

186

0.59

0.95

3.0

2.0

mg/l

2.8

4.1

3.04

181

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

295

2683

1.11

0.95

2.4

4.4

u/l

232.8

247.7

0.85

276

2532

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

242

1.37

0.94

1.4

1.8

ug/l

16.2

23.8

0.82

237

(3004616) Nuclear Ab [Presence] in Serum

293

0.68

0.94

1.6

1.2

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

109

1.56

0.93

1.1

1.2

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

102

0.49

0.89

8.8

2.1

151.6

146.8

—

(44806420)

1.69

0.88

2.5

2.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

105

0.48

0.88

1.2

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

105

0.48

0.88

1.2

1.4

—

(3014051) Protein [Presence] in Urine by Test strip

559

0.78

0.85

2.2

—

(3022145) Colonoscopy Study observation

247

2717

0.90

0.85

1.3

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2474

24391

1.07

0.84

5.2

4.3

mmol/l

4.5

4.7

24.68

2281

22658

(40757373) Influenza virus identified in Isolate

1.76

0.83

1.1

1.8

—

(3032773) Endomysium IgG Ab [Titer] in Serum

188

1.39

0.83

1.1

titre

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

301

1.30

0.82

1.1

1.3

nmol/l

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

353

0.73

0.82

1.0

1.1

—

(3014891) Appearance of Pleural fluid

1.88

0.81

1.7

1.6

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

105

1216

0.86

0.81

2.4

3.4

u/ml

85.4

63.1

0.22

100

1174

(3050794) Legionella sp Ab [Presence] in Serum

0.00

0.79

0.0

1.0

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

684

1.19

0.79

1.9

1.7

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

190

1.37

0.79

1.5

1.2

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

304

1.29

0.78

1.5

nmol/l

0.5

0.3

0.88

232

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

661

0.81

0.78

1.5

1.4

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

124

0.56

0.77

1.3

1.2

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

372

0.75

0.77

1.2

u/ml

2.2

4.9

—

162

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

533

5644

0.93

0.77

3.7

3.8

21.9

21.3

0.33

207

2461

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

594

1.20

0.77

1.5

1.9

iu/l

4.0

4.8

0.29

202

(3017446) Testosterone [Moles/volume] in Serum or Plasma

179

1989

0.89

0.76

2.8

2.3

nmol/l

11.5

13.6

2.86

159

1791

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

291

0.72

0.76

1.3

1.6

68.9

57.5

—

187

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

323

1.27

0.76

1.1

1.3

—

(3032057) Clostridioides difficile [Presence] in Stool

1.70

0.75

1.9

2.0

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

302

0.73

0.75

1.2

1.5

—

(3036489) Thrombin time

907

0.85

0.75

1.5

2.0

20.6

21.4

1.13

789

(4024509)

218

1.33

0.75

1.5

1.6

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

569

1.20

0.74

1.9

2.4

ug/min

63.5

109.9

0.65

348

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

905

0.85

0.73

1.6

1.7

—

(4281824)

254

0.71

0.73

1.2

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

159

1.39

0.72

2.0

1.8

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

299

0.73

0.72

1.2

1.5

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

241

0.70

0.71

1.1

1.2

—

(3003327) Ova and parasites identified in Stool by Light microscopy

757

1.17

0.71

1.8

1.7

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.92

0.70

1.0

1.2

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

343

0.76

0.70

3.7

3.0

u/ml

1711.1

850.1

0.20

329

(3025468) Yersinia sp identified in Specimen by Organism specific culture

297

0.74

0.69

1.2

1.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

297

0.74

0.69

1.2

1.5

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

169

0.65

0.69

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

169

0.65

0.69

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

169

0.65

0.69

1.1

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

248

1.29

0.68

1.1

1.8

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

866

0.85

0.68

2.2

2.4

g/l

3.3

3.1

1.06

679

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

295

0.74

0.67

1.4

1.5

—

(3025130) Human papilloma virus identified in Specimen

267

1.28

0.66

1.3

1.8

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

306

0.75

0.66

1.2

1.5

—

(3049717) Cytology report of Urine Cyto stain

831

0.85

0.66

2.8

2.5

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.79

0.66

1.0

1.3

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.79

0.66

1.8

umol/l

35.8

45.7

—

(40768806) Pleura Pathology biopsy report

224

1.30

0.64

1.3

1.5

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

166

0.66

0.64

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

166

0.66

0.64

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

166

0.66

0.64

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

224

0.71

0.64

1.2

1.4

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

130

0.61

0.63

1.3

1.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

258

0.73

0.63

2.4

1.7

—

(3024263) Appearance of Synovial fluid

129

1.40

0.63

1.3

1.8

—

(4034850)

804

1.15

0.63

12.5

9.6

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

480

0.81

0.63

4.8

5.9

iu/ml

299.7

645.4

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

102

0.59

0.62

1.0

1.1

—

7.5

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

702

1.16

0.62

2.9

3.3

ratio

2.2

1.7

0.24

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.59

0.61

1.1

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.67

0.61

1.2

—

(44806071)

1.67

0.61

1.0

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

152

0.66

0.61

1.0

1.1

u/l

0.9

1.1

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

137

0.66

0.60

2.1

1.6

ug/l

9.3

10.0

—

120

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

165

1.34

0.60

1.1

1.3

—

(3028026) IgM [Mass/volume] in Serum or Plasma

131

1456

0.90

0.60

1.5

1.8

g/l

1.2

1.4

1.07

122

1342

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

1.45

0.59

3.2

4.2

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.56

0.58

1.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

0.00

0.58

0.0

1.0

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

185

0.70

0.58

1.1

—

(3007164) IgA [Mass/volume] in Serum or Plasma

487

4632

1.06

0.58

1.4

g/l

2.3

2.4

0.59

251

2902

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.72

0.57

1.0

1.3

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

202

1.29

0.57

2.2

u/field

2.3

0.00

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

323

3435

0.93

0.56

1.5

1.4

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2448

24214

1.05

0.56

5.0

4.3

mmol/l

1.3

1.5

40.92

2236

22373

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2350

23221

1.05

0.56

16.7

12.9

ml/min/173m2

83.4

81.4

4.06

1849

19291

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

385

0.80

0.56

1.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

0.56

1.0

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

784

0.86

0.55

2.0

2.4

g/l

0.9

0.03

682

(3009871) Measles virus Ab [Titer] in Serum

0.55

1.4

1.6

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

249

1.25

0.53

1.1

1.2

u/l

63.7

54.3

0.28

173

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

228

2450

0.92

0.53

3.2

4.1

ug/l

56.7

17.7

0.57

190

1991

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

158

0.70

0.52

5.0

6.6

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

146

0.68

0.52

1.0

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

724

0.87

0.51

1.5

2.2

g/l

36.1

37.8

1.42

621

(3048929) Epstein Barr virus Ab [Presence] in Serum

713

0.87

0.50

1.1

1.2

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

379

0.82

0.50

1.2

u/ml

4.3

3.2

0.13

119

(3003338) MCHC [Mass/volume]

2086

21133

0.96

0.50

33.7

17.2

g/l

331.8

332.7

4.11

2064

20950

(3033705) Calcium.ionized [Moles/volume] in Venous blood

291

0.79

0.50

2.7

2.6

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

110

1.37

0.48

1.2

1.1

—

(3047189) Immunofixation for 24 hour Urine

107

0.65

0.48

1.1

1.5

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

155

0.71

0.48

1.0

1.2

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.52

0.48

1.6

1.4

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

667

0.87

0.48

3.7

2.9

mg/l

1.7

1.5

0.63

618

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

741

0.87

0.48

1.4

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

1.49

0.47

2.6

2.3

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

720

1.13

0.47

2.9

3.3

mg/l

59.7

67.7

0.18

587

(3045142) Bone marrow Pathology biopsy report

277

0.79

0.46

1.4

1.3

—

(44790047)

264

1.21

0.45

1.2

1.6

—

(44790048)

264

1.21

0.45

1.2

1.6

—

(44806118)

264

1.21

0.45

1.2

1.6

—

(44790049)

264

1.21

0.45

1.2

1.6

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

722

1.13

0.45

2.9

3.3

mg/l

37.8

55.8

0.74

589

(3028308) Erythrocytes [#/volume] in Pleural fluid

237

1.23

0.45

1.6

1.4

e6/l

32895.6

96864.3

0.79

139

(21494434) Karyotype in Bone marrow

209

0.76

0.45

1.1

1.2

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

687

7099

0.96

0.44

3.8

4.3

ug/l

3.8

3.1

0.11

600

6409

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

307

0.81

0.43

1.2

1.5

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

181

1942

0.93

0.43

3.1

2.6

ml/min/173m2

69.0

66.8

0.26

777

(3041354) Potassium [Moles/volume] in Venous blood

296

0.81

0.43

2.6

mmol/l

4.1

0.27

291

(3035285) Chloride [Moles/volume] in Venous blood

296

0.81

0.43

2.6

mmol/l

105.2

105.5

0.26

291

(3016750) Collection duration of Urine

148

1.29

0.43

1.6

2.2

min

535.5

494.9

0.78

110

(3027456) Digoxin [Moles/volume] in Serum or Plasma

536

1.14

0.43

3.9

3.1

nmol/l

0.7

0.8

1.56

413

(40768441) Liver Pathology biopsy report

184

0.76

0.41

1.1

1.4

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

169

1573

1.08

0.41

1.3

1.2

—

(3005719) IgG [Mass/volume] in Serum or Plasma

173

1855

0.93

0.41

2.0

2.7

g/l

10.7

10.6

0.17

158

1696

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

661

1.12

0.41

1.4

1.5

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

133

1226

1.09

0.41

1.4

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.52

0.41

6.2

4.9

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.41

0.0

4.7

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.41

0.0

1.1

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

0.41

0.0

1.1

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

0.41

0.0

1.0

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.00

0.40

0.0

1.0

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.40

0.0

1.1

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

0.00

0.40

0.0

1.0

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

0.00

0.40

0.0

1.0

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.40

0.0

1.1

—

(3003577) Lead [Moles/volume] in Blood

0.00

0.40

0.0

1.7

—

0.2

—

(21494890) Protein electrophoresis panel - 24 hour Urine

232

1.21

0.39

1.9

2.0

—

(3037522) Nuclear Ab [Titer] in Serum

314

3295

0.95

0.39

1.3

titre

597.8

510.5

0.27

671

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

103

0.68

0.39

1.1

2.2

ug/l

13.5

329.1

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.00

0.39

0.0

1.0

—

(3023419) Bacteria identified in Sputum by Culture

307

1.17

0.38

1.9

2.6

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

684

0.89

0.37

1.2

1.1

—

(3022689) Creatine [Moles/volume] in Urine

1.32

0.37

1.6

1.5

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

376

0.85

0.37

1.1

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

257

0.82

0.37

2.4

—

(3022621) pH of Urine by Test strip

167

1564

1.07

0.36

3.4

3.1

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.43

0.35

2.0

1.5

ng/l

86.2

106.0

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

117

1.28

0.35

1.3

1.4

umol/l

23.8

23.9

0.00

109

(3002619) Bacteria identified in Specimen by Culture

1.40

0.35

1.3

1.0

—

(4027681)

156

0.77

0.34

1.2

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.36

0.34

1.0

1.3

—

(3037121) Protein [Mass/volume] in Urine

805

1.10

0.34

2.1

3.3

g/l

0.3

0.01

327

(3012441) Differential panel - Pleural fluid

218

1.19

0.34

1.5

1.4

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

144

0.76

0.33

1.5

1.3

—

(40760888) Immunoglobulin light chains.free panel - Serum

539

1.12

0.33

3.0

3.3

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

284

1.16

0.33

1.4

1.3

mmol/l

8.2

7.2

1.04

214

(3036071) Salmonella sp Ab [Titer] in Serum

0.69

0.33

1.0

1.1

—

(3034426) Prothrombin time (PT)

0.67

0.33

1.2

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

350

1.14

0.32

1.4

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.28

0.32

1.2

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

209

0.81

0.32

1.5

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

143

0.77

0.32

1.5

1.3

—

(4268621)

251

0.84

0.31

2.3

—

(21491868) Cryoglobulin [Mass/volume] in Serum

0.71

0.30

1.1

1.2

—

0.3

—

(3004775) Volume in Urine collected for unspecified duration

193

1.19

0.30

1.8

2.3

771.4

640.9

0.48

132

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

0.71

0.30

1.0

2.2

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

0.71

0.30

1.0

2.2

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

147

1.23

0.30

1.2

1.1

ratio

1.2

1.0

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

100

0.70

0.30

1.0

2.2

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

486

1.11

0.30

1.5

1.4

—

(3051593) INR in Capillary blood by Coagulation assay

102

1.28

0.30

8.4

12.9

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

909

1.08

0.29

1.7

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

409

0.88

0.29

1.3

1.8

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

130

0.77

0.29

1.8

1.5

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

151

0.79

0.28

1.7

1.5

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

412

1.12

0.28

1.0

1.1

iu/ml

1.2

1345.2

—

100

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

129

0.77

0.28

1.8

1.5

—

(4211845)

116

0.78

0.27

3.7

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

118

0.76

0.27

1.0

1.1

—

(3026250) Tacrolimus [Mass/volume] in Blood

119

0.76

0.27

32.1

31.7

ug/l

6.4

7.6

—

105

(3011985) Renin [Units/volume] in Plasma

309

1.13

0.27

1.3

1.4

mu/l

22.9

50.0

1.56

274

(40765089) Chromosome analysis panel - Blood by G-banded

1.21

0.26

1.0

—

(40768797) Stomach Pathology biopsy report

324

3354

0.96

0.26

1.3

1.2

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

0.70

0.26

1.2

121.6

104.6

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.68

0.26

1.4

1.5

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

444

1.11

0.25

1.5

1.4

u/ml

106.8

117.0

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

570

1.09

0.24

1.3

1.7

—

(3007461) Platelets [#/volume] in Blood

2761

27503

1.04

0.24

35.0

19.9

e9/l

254.3

250.8

1.93

2690

26806

(3043410) Blood group antigens tested for on Red Blood Cells

1.17

0.24

1.6

1.3

—

(3024932) HLA-DR beta [Type]

0.74

0.24

1.0

1.1

—

(3024471) HLA-A [Type]

0.71

0.24

1.0

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

243

0.86

0.23

1.2

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

264

0.87

0.23

1.5

1.7

—

(3024869) Neuronal Ab [Presence] in Serum

1.28

0.23

1.2

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

168

0.83

0.22

1.9

2.3

—

(4306422)

379

0.90

0.22

1.2

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

157

0.83

0.22

1.3

1.5

u/l

2.8

6.1

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

0.21

0.0

4.0

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

156

0.83

0.21

1.2

1.7

—

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

0.00

0.21

0.0

1.3

—

0.8

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.1

—

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

0.00

0.21

0.0

1.3

—

1.4

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.21

0.0

1.2

—

2.3

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

0.00

0.21

0.0

1.3

—

0.5

—

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

0.00

0.21

0.0

1.3

—

0.9

—

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

0.00

0.21

0.0

1.3

—

1.0

—

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

0.00

0.21

0.0

1.3

—

2.0

—

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

0.00

0.21

0.0

1.3

—

2.8

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

0.00

0.21

0.0

1.3

—

2.4

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

0.00

0.21

0.0

1.4

—

0.7

—

(3007700) Barley IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.2

—

0.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

408

0.91

0.21

1.2

1.5

—

(3024731) MCV [Entitic volume]

2761

27516

1.03

0.20

34.7

19.9

90.6

90.9

2.95

2712

27115

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

198

0.86

0.20

1.0

1.2

mg/l

34.4

42.6

0.54

164

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

166

0.84

0.20

1.2

1.3

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

441

1.09

0.20

1.9

3.1

—

(3035880) pH of Pleural fluid

123

0.81

0.20

1.2

1.4

—

(3036525) Urea [Moles/time] in 24 hour Urine

0.00

0.20

0.0

3.8

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.20

0.0

1.1

—

(3007542) Rye IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.1

—

0.2

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

208

0.86

0.20

1.1

1.3

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

548

1.08

0.20

1.3

1.7

—

(3026361) Erythrocytes [#/volume] in Blood

2761

27519

1.03

0.20

34.9

19.9

e12/l

4.5

0.33

2681

26746

(3015171) Extractable nuclear Ab [Units/volume] in Serum

932

0.94

0.19

1.1

1.2

u/ml

0.1

0.9

—

(3038515) Glucose [Moles/volume] in Venous blood

479

0.92

0.19

3.1

3.3

mmol/l

8.3

7.6

0.66

468

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

231

1.13

0.19

1.1

1.9

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

1.22

0.19

1.3

1.2

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

1.15

0.19

1.0

1.3

—

141.3

—

(3023199) Leukocytes [#/volume] in Pleural fluid

270

1.11

0.18

1.6

1.4

e6/l

2569.3

1513.8

0.48

194

(3044927) Protein electrophoresis panel - Urine

238

0.88

0.18

1.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

164

0.85

0.18

1.2

1.3

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

487

0.92

0.18

1.1

1.2

—

(3035941) MCH [Entitic mass]

2760

27516

1.03

0.18

34.7

19.8

30.1

30.3

7.93

2711

27113

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

119

1.18

0.17

1.1

u/l

46.9

80.9

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

233

1.12

0.17

2.3

3.6

55.4

56.5

0.06

153

(3000963) Hemoglobin [Mass/volume] in Blood

2761

27528

1.03

0.17

35.1

20.0

g/l

135.0

136.2

3.72

2710

27130

(3042631) Mycobacterium sp identified in Specimen

310

1.10

0.17

2.6

2.7

—

(44813793)

157

1.15

0.17

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

403

0.92

0.17

1.3

1.2

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

1.22

0.17

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

0.76

0.17

1.0

1.6

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

120

1.17

0.16

1.1

u/l

14.3

24.0

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.13

0.16

1.0

1.2

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.11

0.16

1.4

1.2

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

462

0.93

0.15

1.1

1.2

u/ml

301.9

264.8

0.41

284

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

140

1.14

0.15

1.6

1.3

—

70.0

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

129

0.85

0.14

1.2

1.7

—

(40768446) Kidney Pathology biopsy report

0.79

0.14

2.1

1.6

—

(3010813) Leukocytes [#/volume] in Blood

2760

27530

1.02

0.14

35.1

20.0

e9/l

7.1

6.7

15.83

2678

26757

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

551

0.94

0.13

1.2

1.5

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

653

0.95

0.13

1.3

miu/ml

256.2

211.5

0.26

301

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

366

0.93

0.13

1.2

1.1

115.3

115.9

0.04

337

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

238

1.09

0.13

1.0

1.1

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

127

0.87

0.12

1.1

2.0

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

127

0.87

0.12

1.1

2.0

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

127

0.87

0.12

1.1

2.0

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

127

0.87

0.12

1.1

2.0

—

(3042733) HLA Ab [Presence] in Serum

1.18

0.12

4.8

5.0

—

(1761482) Bacteria [#/volume] in Urine by Culture

599

0.95

0.11

4.2

4.6

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

211

1.09

0.11

1.4

1.2

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

1.16

0.11

1.0

1.1

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

167

0.90

0.10

1.2

1.1

nmol/l

4.4

1.4

—

(3000093) Morphology [Interpretation] in Blood Narrative

202

1.09

0.10

1.0

1.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

299

2942

1.02

0.09

4.6

4.4

31.0

32.0

0.84

212

1990

(3037756) Immunofixation for Serum or Plasma

492

0.95

0.09

1.6

1.5

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.09

0.08

1.0

1.2

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

784

1.03

0.08

2.1

3.0

u/ml

0.4

0.3

0.92

451

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

470

0.96

0.08

2.0

1.6

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.03

0.07

1.0

1.1

—

(3020630) Protein [Mass/volume] in Serum or Plasma

192

1953

0.98

0.07

2.8

2.6

g/l

65.5

66.4

0.87

174

1784

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

1.05

0.07

1.1

—

(40768443) Skin Pathology biopsy report

105

1025

1.03

0.07

1.2

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

0.86

0.07

1.1

1.4

ug/l

12.2

9.0

—

(3028433) Virus identified in Specimen by Culture

0.85

0.07

1.0

1.3

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

501

1.04

0.07

1.4

1.5

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

873

0.97

0.07

2.5

3.5

u/ml

1333.7

4747.9

0.51

744

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

204

0.93

0.07

1.1

1.8

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

204

0.93

0.07

1.1

1.8

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

204

0.93

0.07

1.1

1.8

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

122

0.90

0.07

1.1

1.2

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

0.84

0.06

1.1

1.2

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

132

0.91

0.06

3.1

2.3

95.8

95.5

0.01

125

(3006462) Nitrate [Presence] in Urine

104

0.86

0.06

3.7

3.8

—

(3020491) Glucose [Moles/volume] in Blood

197

1.07

0.06

1.7

2.3

mmol/l

6.2

7.0

0.84

128

(3011648) Oxygen content in Venous blood

197

1.07

0.06

1.5

1.9

11.3

11.1

0.07

197

(40768793) Breast Pathology biopsy report

568

0.97

0.06

1.3

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

256

1.06

0.06

2.9

4.2

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

618

0.97

0.06

1.5

1.2

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

217

1.06

0.06

1.6

1.5

27.4

34.0

0.42

137

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

524

1.03

0.05

1.2

1.4

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

238

1.05

0.05

3.3

3.9

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

130

0.92

0.04

1.4

1.3

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

298

1.04

0.04

1.3

1.1

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

241

0.95

0.04

1.5

1.3

e6/l

13745.6

94326.4

1.20

166

(3045414) Leukocytes [Presence] in Urine

110

1084

1.02

0.03

1.7

1.9

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

309

1.04

0.03

1.3

1.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

129

0.93

0.03

1.2

1.7

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

230

0.96

0.03

3.0

5.0

u/ml

65.8

84.7

—

(3045788) Cell count panel - Pleural fluid

219

0.96

0.03

1.7

1.4

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

390

0.97

0.02

1.8

1.4

—

(3044941) Cell count panel - Synovial fluid

390

0.97

0.02

1.8

1.5

—

(3051651) Icteric interference index of Serum or Plasma

148

0.95

0.02

4.4

3.4

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

162

1.05

0.02

1.0

1.2

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

163

1.04

0.01

2.0

1.5

ug/l

3.3

4.8

0.43

138

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

403

1.02

0.01

1.4

1.5

—

(3004588) Protein electrophoresis panel - Serum or Plasma

161

1618

0.99

0.01

2.3

—

(3051611) Lipemic interference index of Serum or Plasma

254

1.02

0.00

3.7

3.4

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

864

1.01

0.00

1.9

nmol/l

37.3

0.00

840

(1617658) Protocol used for examination of sentinel lymph nodes

203

0.99

0.00

1.1

1.0

—

(3017704) Immunofixation for Urine

130

1.00

0.00

1.6

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

103

0.97

0.00

1.1

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

325

0.98

0.00

1.3

1.6

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

322

0.99

0.00

1.4

1.5

—

(3004451) EKG impression Narrative

122

0.98

0.00

1.0

1.3

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

188

1.01

0.00

1.5

1.6

—

(40768795) Lymph node Pathology biopsy report

227

1.01

0.00

1.2

—

(3021788) Differential panel - Synovial fluid

433

0.99

0.00

1.5

1.6

—

(3000475) Leukocytes [#/volume] in Synovial fluid

594

0.99

0.00

1.9

1.7

e6/l

16256.5

13948.8

0.11

429

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

292

0.99

0.00

1.3

1.4

pmol/l

280.5

308.7

0.22

225

(3005082) Progesterone [Moles/volume] in Serum or Plasma

0.88

0.00

1.2

nmol/l

30.9

28.7

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

0.96

0.00

1.4

1.2

105.3

110.5

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.3

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

0.90

0.00

1.4

1.1

g/l

0.3

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.0

1.4

—

2.7

—

(3034614) HLA Ag [Interpretation]

0.00

0.0

1.3

—

(3042301) Urate [Moles/volume] in Synovial fluid

0.00

0.0

1.0

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.02

0.00

1.0

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

0.0

1.0

—

(3013862) HLA-DP [Type]

0.00

0.0

1.0

—

(40760409) HLA-A [Type] by High resolution

0.00

0.0

1.0

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

0.00

0.0

1.0

—

1289.3

—

(40760410) HLA-B [Type] by High resolution

0.00

0.0

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.00

0.0

4.1

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3032333) Phosphate [Mass or Moles] in 24 hour Urine

0.00

0.0

1.1

—

(3016135) IgD [Mass/volume] in Serum

0.00

0.0

1.4

—

139.5

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

0.95

0.00

1.0

2.3

—

(40763590) HLA-DQ beta [Type]

0.00

0.0

1.0

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.0

1.4

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3035933) Granulocytes/100 leukocytes in Blood

0.88

0.00

7.0

1.4

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

0.00

0.0

2.2

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.2

—

1.2

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.00

0.0

1.0

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.0

6.0

—

0.3

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

0.0

1.1

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(4133840)

0.91

0.00

1.0

1.1

—

(3011325) HIV 1+2 Ab [Presence] in Serum

0.00

0.0

1.0

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.0

1.0

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

0.99

0.00

1.0

1.2

—

(3004282) Tumor necrosis factor.alpha [Mass/volume] in Serum or Plasma

0.00

0.0

3.0

—

52.2

—

(46236302) HLA-C [Type] by High resolution typing

0.00

0.0

1.0

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.97

0.00

1.0

1.1

—

(3037556) Urate [Mass/volume] in Serum or Plasma

0.92

0.00

1.3

1.4

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint F5_DELUSIO and mortality.

Females

Parameter	HR [95% CI]	p-value
F5_DELUSIO	1.636 [1.51, 1.78]	< 0.001
Birth year	1.001 [0.99, 1.01]	0.89

During the follow-up period (1.1.1998 — 31.12.2019), 5697 out of 15031 females with F5_DELUSIO died.

Males

Parameter	HR [95% CI]	p-value
F5_DELUSIO	2.41 [2.17, 2.68]	< 0.001
Birth year	0.99 [0.98, 1.0]	0.035

During the follow-up period (1.1.1998 — 31.12.2019), 2977 out of 9525 males with F5_DELUSIO died.

Mortality risk

Mortality risk for people of age

years, who have F5_DELUSIO.

N-year risk	Females	Males
1	0.176%	0.508%
5	1.142%	2.751%
10	2.591%	7.179%
15	5.227%	13.059%
20	9.441%	21.687%

Relationships between endpoints

↥

Index endpoint: F5_DELUSIO – Persistent delusional disorders

GWS hits: 2

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Persistent delusional disorders

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints